Authors:
Sacchi, S
Federico, M
Vitolo, U
Boccomini, C
Vallisa, D
Baldini, L
Petrini, M
Rupoli, S
Di Raimondo, F
Merli, F
Liso, V
Tabilio, A
Saglio, G
Vinci, G
Brugiatelli, M
Dastoli, G
Citation: S. Sacchi et al., Clinical activity and safety of combination immunotherapy with interferon-alpha 2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma, HAEMATOLOG, 86(9), 2001, pp. 951-958
Authors:
Marmont, F
Allione, B
Audisio, E
Boccomini, C
Ciocca, V
D'Ardia, S
Falda, M
Locatelli, F
Gallo, E
Citation: F. Marmont et al., A landmark analysis of survival by response category in elderly patients with acute myeloblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 644-646
Authors:
Federico, M
Vitolo, U
Zinzani, PL
Chisesi, T
Clo, V
Bellesi, G
Magagnoli, M
Liberati, M
Boccomini, C
Niscola, P
Pavone, V
Cuneo, A
Santini, G
Brugiatelli, M
Baldini, L
Rigacci, L
Resegotti, L
Citation: M. Federico et al., Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases, BLOOD, 95(3), 2000, pp. 783-789
Authors:
Calvi, R
Bertini, M
Boccomini, C
Botto, B
Orsucci, L
Vitolo, U
Citation: R. Calvi et al., Burkitt's lymphomas in adults: retrospective analysis of 30 cases treated with two different schemes, HAEMATOLOG, 84(4), 1999, pp. 383-384